Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Oct 2016 16:46

RNS Number : 5015M
Sinclair Pharma PLC
13 October 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Sinclair Pharma PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

x

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation:

Soros Fund Management LLC

4. Full name of shareholder(s) (if different from 3.):

Morgan Stanley & Co. LLC

5. Date of the transaction and date onwhich the threshold is crossed orreached:

October 12, 2016

6. Date on which issuer notified:

October 13, 2016

7. Threshold(s) that is/are crossed orreached:

5%

     
 

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0033856740

25,000,000

25,000,000

N/A

N/A

25,000,000

N/A

4.97%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

N/A

Below 5%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

Grace Shin

15. Contact telephone number:

+1 212 320 5554

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMJBATMBIBBIF
Date   Source Headline
24th Sep 20182:13 pmRNSForm 8.3 - Sinclair Pharma Plc
24th Sep 20181:58 pmBUSForm 8.3 - Sinclair Pharma plc - Amendment
24th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
24th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
24th Sep 20187:00 amBUSForm 8.3 - Sinclair Pharma plc
21st Sep 20183:48 pmRNSRobert Stuart Swanson-Form 8.3 Sinclair Pharma plc
21st Sep 20183:14 pmRNSForm 8.3 - Sinclair Pharma PLC
21st Sep 20182:18 pmRNSForm 8.3 - Sinclair Pharma PLC
21st Sep 20181:58 pmBUSForm 8.3 - Sinclair Pharma plc
21st Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
21st Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
20th Sep 20183:06 pmRNSForm 8.3 - Sinclair Pharma Plc
20th Sep 20182:55 pmBUSForm 8.3 - Sinclair Pharma plc
20th Sep 20182:42 pmRNSForm 8.3 - Sinclair Pharma
20th Sep 20182:34 pmRNSForm 8.3 - Sinclair Pharma Plc
20th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
20th Sep 20188:52 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
20th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma PLC
19th Sep 20183:29 pmRNSHolding(s) in Company
19th Sep 20182:29 pmRNSForm 8.3 - [Sinclair Pharma PLC]
19th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Sep 201810:29 amRNSForm 8.3 - SINCLAIR PHARMA PLC
19th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
18th Sep 20182:55 pmRNSForm 8.3 - Sinclair Pharma Plc
18th Sep 20182:53 pmRNSForm 8.3 - Sinclair Pharma Plc
18th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Sep 20189:36 amRNSForm 8.3 - SINCLAIR PHARMA PLC
18th Sep 20188:14 amRNSHolding(s) in Company
18th Sep 20188:02 amRNSRecommended Cash Offer for Sinclair Pharma plc
18th Sep 20188:01 amRNSRecommended Cash Offer for Sinclair Pharma plc
18th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
17th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
17th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
14th Sep 201812:08 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
14th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
13th Sep 20181:49 pmRNSForm 8.3 - Sinclair Pharma plc
13th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12th Sep 201810:35 amRNSForm 8.3 - SINCLAIR PHARMA PLC
12th Sep 20189:52 amRNSForm 8.3 - Sinclair Pharma Plc
12th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma PLC
11th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Sep 20189:58 amRNSResponse to update re possible offer for Sinclair
11th Sep 20189:52 amRNSForm 8.3 - SINCLAIR PHARMA PLC
11th Sep 20189:46 amRNSUpdate re Possible Offer for Sinclair Pharma plc
10th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
7th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
6th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
5th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.